YS Biopharma Co., Ltd. (YS) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
YS Biopharma Co., Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
773
First IPO Date
August 05, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Dave Chenn | Co-Chief Executive Officer | 0 | N/A |
| Hui Shao | Co-Chief Executive Officer, President, Chief Business Officer & Executive Director | 0 | 1968 |
| Chunyuan Wu | Chief Financial Officer & Director | 0 | 1978 |
| Gang Li | Head of Marketing & Sales | 0 | 1982 |
| Yuan Liu | Head of Vaccine Research | 0 | 1987 |
| Zenaida Reynoso Mojares | Chief Medical Officer | 0 | 1959 |
Description
YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China, in 2002, specializes in the discovery, development, production, and commercialization of vaccines and therapeutic biologics. Their primary focus is on addressing infectious diseases and cancer. Central to their efforts is a proprietary PIKA immunomodulating technology platform, which supports the creation of preventive and therapeutic biologics for conditions such as Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. The company extends its operations across multiple countries, including China, the United States, Singapore, the United Arab Emirates, and the Philippines.
